Sphinx Scientific Laboratory (Tianjin) Co., Ltd. is a company engaged in the research and production of pharmaceutical intermediates. Founded in December 2009, the company is headquartered in the Tianjin Economic and Technological Development Zone (TEDA), which is the core functional area of Binhai New Area, Tianjin. It boasts an R&D center of more than 16,000 square meters, and is fully equipped with all the necessary facilities including a hazardous chemical warehouse and a wastewater treatment station. 

       In addition, Sphinx has other three facilities:  

1.) Production plant, 20,000 m²(Baotou, Neimeng) ;

2.) Production plant, 2,000 m²(Panjin, Liaoning);

3.) Production plant, 110,000 m²(Huairen, Shanxi).

       Quality and EHS systems are to ensure that all the activities carried out in Sphinx are well managed according to related regulations. At present, seven RSM commercialization projects for new drug registration have been successfully launched into production.

       The company possessesmany new and leading technologies and has rich experience in the fields of asymmetric synthesis, aliphatic ring construction, continuous reaction, photoreactionand biological enzyme synthesis. Built upon technical innovation, the company has continuously applied itsunique core technologies in many challenging projects.

       It is our belief that responsibility will not stop at delivery and innovation is a never ending endeavor. Continuous optimization is the main theme of every project awarded to Sphinx.

       Always keeping our mission and key value in mind, Sphinx is committed to greener and saferprocesses. Sphinx will continue to help facilitatenew drug development in Chinaand around the world.

In Sphinx, our Scientists are focusing on chemistry while caring about the health of mankind. Our Scientists are devoting their passion and wisdom in the use of cutting-edge chemistry to serve the pharmaceutical industry and to accelerate global drug development.All for mankind’s health!

Never forget our beginning, after seven years of hardwork , we have enjoyed significant success. From the beginning of 5-6 staff to the present 130+ people, from the beginning of 500 m² to 10,000 m² of  providing integrated CDO & CMO services spanning across R & D and production of pharmaceuticals, from a small private company to a public company successfully on the stockmarket last year. I wish to extend my gratitude to all of our clients and friends representing different industries, and thank all Sphinx employees who have joined our company from the very beginning to now, and thank all share -holders who have continuously placed their faith in me. 

10 years, 50 years, and forever, Sphinx will always adhere to the philosophy "the best career stage for the staff, the best service providers for the pharmaceutical industry, and the best investment platform for the shareholders," and move forward with deep social responsibility and continuously adhere to the great cause of mankind’ s health.